Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy

Blood Adv. 2023 Nov 14;7(21):6710-6716. doi: 10.1182/bloodadvances.2023010665.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD19
  • Fluorodeoxyglucose F18*
  • Humans
  • Immunotherapy, Adoptive
  • Lymphoma* / therapy
  • Neoplasm Recurrence, Local / diagnostic imaging
  • Positron Emission Tomography Computed Tomography

Substances

  • Fluorodeoxyglucose F18
  • Antigens, CD19